These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31430374)

  • 1. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
    Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
    Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
    Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
    Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
    [No Abstract]   [Full Text] [Related]  

  • 3. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
    Wei M; Liu B; Gu Q; Su L; Yu Y; Zhu Z
    Cell Oncol (Dordr); 2013 Feb; 36(1):79-93. PubMed ID: 23184467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho GTPase Activating Protein 24 (ARHGAP24) Silencing Promotes Lung Cancer Cell Migration and Invasion by Activating β-Catenin Signaling.
    Wang L; Shen S; Wang M; Ding F; Xiao H; Li G; Hu F
    Med Sci Monit; 2019 Jan; 25():21-31. PubMed ID: 30599132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.
    Dai X; Geng F; Dai J; Li M; Liu M
    Med Sci Monit; 2018 Nov; 24():8669-8677. PubMed ID: 30499465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VCP/p97 targets the nuclear export and degradation of p27
    Shi X; Zhu K; Ye Z; Yue J
    FASEB J; 2020 Apr; 34(4):5193-5207. PubMed ID: 32067276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer.
    Guo Q; Xiong Y; Song Y; Hua K; Gao S
    Gene; 2019 Apr; 692():9-16. PubMed ID: 30641218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARHGAP24 inhibits cell cycle progression, induces apoptosis and suppresses invasion in renal cell carcinoma.
    Xu G; Lu X; Huang T; Fan J
    Oncotarget; 2016 Aug; 7(32):51829-51839. PubMed ID: 27385097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
    Li N; Zeng J; Sun F; Tong X; Meng G; Wu C; Ding X; Liu L; Han M; Lu C; Dai F
    Cell Cycle; 2018; 17(19-20):2335-2348. PubMed ID: 30317923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-Binding RING E3-Ligase DZIP3/hRUL138 Stabilizes Cyclin D1 to Drive Cell-Cycle and Cancer Progression.
    Kolapalli SP; Sahu R; Chauhan NR; Jena KK; Mehto S; Das SK; Jain A; Rout M; Dash R; Swain RK; Lee DY; Rusten TE; Chauhan S; Chauhan S
    Cancer Res; 2021 Jan; 81(2):315-331. PubMed ID: 33067265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
    Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
    BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CACYBP Enhances Cytoplasmic Retention of P27
    Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH
    Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p.
    Chao H; Zhang M; Hou H; Zhang Z; Li N
    Life Sci; 2020 Feb; 243():117296. PubMed ID: 31935390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of WWP2 suppresses proliferation, and induces G1 cell cycle arrest and apoptosis in liver cancer cells.
    Xu SQ; Qin Y; Pan DB; Ye GX; Wu CJ; Wang S; Jiang JY; Fu J; Wang CJ
    Mol Med Rep; 2016 Mar; 13(3):2261-6. PubMed ID: 26783238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of WWP2 in human lung adenocarcinoma and its effect on migration and invasion.
    Yang R; He Y; Chen S; Lu X; Huang C; Zhang G
    Biochem Biophys Res Commun; 2016 Oct; 479(2):146-151. PubMed ID: 27462019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of RCC1 sensitizes immunotherapy by up-regulating PD-L1 via p27
    Zeng X; Zhong M; Yang Y; Wang Z; Zhu Y
    J Cell Mol Med; 2021 Apr; 25(8):4136-4147. PubMed ID: 33630417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.